Detection of anti-streptococcal, antienolase, and anti-neural antibodies in subjects with early-onset psychiatric disorders

Actas Espanolas de Psiquiatria

Volumn 43, Issue 2, 2015, Pages 35-41

  Nicolini, Humberto ^a,b,c   López, Yaumara ^d   Genis Mendoza, Alma D ^a,c   Manrique, Viana ^d   Lopez Canovas, Lilia ^a   Niubo, Esperanza ^d   Hernández, Lázaro ^f   Bobes, María A ^d   Riverón, Ana M ^a   López Casamichana, Mavil ^a   Flores, Julio ^c   Lanzagorta, Nuria ^b   De La Fuente Sandoval, Camilo ^e   Santana, Daniel ^b  

^a UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^b Grupo Medico Carracci   (Mexico)

^c Secretaria de Salud   (Mexico)

^d CENTRO DE NEUROCIENCIAS DE CUBA   (Cuba)

^e Instituto Nacional de Neurología INNMVS   (Mexico)

^f Clinica del Adolescente   (Cuba)

Author keywords

Anti neural antibodies; Auto antibodies; Enolase; Obsessive compulsive disorder; PANDAS; Streptococcus

Indexed keywords

ANTIBODY; ENOLASE;

BLOOD; CHILD; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MENTAL DISEASE; MICROBIOLOGY; NERVOUS SYSTEM; OBSESSIVE COMPULSIVE DISORDER; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TIC;

ANTIBODIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NERVOUS SYSTEM; OBSESSIVE-COMPULSIVE DISORDER; PHOSPHOPYRUVATE HYDRATASE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIC DISORDERS;

EID: 84937806235     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cohen-Poradosu R, Kasper DL. Group A Streptococcus epidemiology and vaccine implications. Clinical Infectious Diseases. 2007;45: 863-5.
2. Kiessling LS, Marcotte AC, Culpepper L. Antineural antibodies in movement disorders. Pediatrics. 1993;92: 39-43.
3. Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, et al. Invasive Group A streptococcal infections in North Carolina: Epidemiology, clinical features, and genetic and serotype analysis of causative organisms. The Journal of Infectious Diseases. 1997;176: 992-1000.
4. Swedo SE, Leonard HL, Garvey MA, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry. 1998;155: 264-71.
5. Swedo SE, Leonard HL, Rapoport JL. The Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS) Subgroup: Separating fact from fiction. Pediatrics. 2004;113: 907-11.
6. Paul SP, Jerwood S. Group A streptococcal septicemia, meningitis and cerebral abscess: Case report and literature review. Turk J Pediatr. 2012;54: 180-3.
7. Snider LA, Swedo SE. Post-streptococcal autoimmune disorders of the central nervous system. Current Opinion in Neurology. 2003;16: 359-65.
8. Pavone P, Bianchini R, Parano E, Incorpora G, Rizzo R, Mazzone L, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30: 107-10.
9. Filardi da Rocha F, Correa H, Teixeira AL. Obsessive-compulsive disorder and immunology: A review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2008;32: 1139-46.
10. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydernham's chorea. Neurology. 2002;9: 227-31.
11. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35: 113-25.
12. Gieseker KE, Roe MH, MacKenzie T, Todd JK. Evaluating the American Academy of Pediatrics Diagnostic Standard for Streptococcus pyogenes pharyngitis: Backup Culture Versus Repeat Rapid Antigen Testing. Pediatrics. 2003;111: 666-70.
13. Russell H, Facklam RR. Guanidine extraction of streptococcal M protein. Infect Immun. 1975;12: 679-86.
14. Dale RS, Clander PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neural surface glycolitic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Journal of Neuroinmunology. 2006;172: 187.
15. Sakimura K, Kushiya E, Obinata M, Odani S, Takahashi Y. Molecular cloning and the nucleotide sequence of cDNA for neuron-specific enolase messenger RNA of rat brain. Proc Natl Acad Sci USA. 1985;82: 7453-7.
16. Gause C, Morris C, Vernekar S, Pardo-Villamizar C, Grados MA, Singer HS. Antineuronal antibodies in OCD: Comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol. 2009;214: 118-24.
17. Dale RC, Church AJ, Surtees R, Lees AJ, Adcock J E, Harding B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004;127: 21-33.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 20: 34-57.
19. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale, I: Development, use, and reliability. Arch Gen Psychiatry. 1989;46: 1006-11.
20. Nicolini H, Orozco B, Sanchez de Carmona M, Paez F, Loreido G, De La Fuente JR. Estudio de traduccion y confiabilidad de la escala Yale-Brown en espanol para trastorno obsesivocompulsivo. Salud Mental. 1996;19: 13-6.
21. Ulloa RE, De La Pena F, Palacios L, Nicolini H, Avila JM. Estudio de validez y confiabilidad de la version en espanol de la escala Yale-Brown del trastorno obsesivo compulsivo para ninos y adolescentes. Actas Esp Psiquiatr. 2004;32: 216-21.
22. Jerwood S, Hankins M, Cohen J. A pilot clinical trial to evaluate a novel time-to-positivity assay to measure the effectiveness of antibiotic therapy for septic patients in intensive cae. J Crit Care. 2012;27: 320.
23. Maia TV, Cooney RE, Peterson BS. The neural bases of obsessivecompulsive disorder in children and adults B. Dev Psychopathol. 2008;20: 1251-83.